News
EVAX
3.340
+2.45%
0.080
H.C. Wainwright Sticks to Its Buy Rating for Evaxion Biotech (EVAX)
TipRanks · 4d ago
Weekly Report: what happened at EVAX last week (0914-0918)?
Weekly Report · 5d ago
Evaxion Expands AI-Immunology Platform into Autoimmune Diseases
TipRanks · 09/14 12:35
Weekly Report: what happened at EVAX last week (0907-0911)?
Weekly Report · 09/14 10:16
Weekly Report: what happened at EVAX last week (0831-0904)?
Weekly Report · 09/07 10:09
Evaxion Biotech Boosts Share Capital With August 2026 ATM ADS Offering
TipRanks · 09/04 11:28
Analysts Offer Insights on Healthcare Companies: GH Research (GHRS), Evaxion Biotech (EVAX) and Ibio (IBIO)
TipRanks · 08/31 14:00
Weekly Report: what happened at EVAX last week (0824-0828)?
Weekly Report · 08/31 10:16
Analysts’ Top Healthcare Picks: Ramsay Health Care (RMSYF), Evaxion Biotech (EVAX)
TipRanks · 08/27 16:50
Weekly Report: what happened at EVAX last week (0817-0821)?
Weekly Report · 08/24 10:17
Analysts Are Bullish on These Healthcare Stocks: Evaxion Biotech (EVAX), Opus Genetics (IRD)
TipRanks · 08/21 14:00
Analysts Offer Insights on Healthcare Companies: Evaxion Biotech (EVAX) and Boston Scientific (BSX)
TipRanks · 08/21 13:30
Analysts’ Top Healthcare Picks: Evaxion Biotech (EVAX), Ultragenyx Pharmaceutical (RARE)
TipRanks · 08/21 11:10
Evaxion Biotech Earnings Call: Data Strength, Cash Strain
TipRanks · 08/21 00:02
Evaxion Biotech Q2 2026 Earnings Call: Complete Transcript
Benzinga · 08/20 13:34
Evaxion Reports Q2 Loss; Advances Cancer And Infectious Disease Vaccine Pipeline
NASDAQ · 08/20 13:10
Evaxion Biotech Posts Continued Losses in Q2 2026 SEC Filing
TipRanks · 08/20 11:57
Evaxion posts Q2 loss but extends cash runway as AI-Immunology vaccine pipeline advances
TipRanks · 08/20 11:57
Evaxion Biotech GAAP EPS of -$0.01 in-line
Seeking Alpha · 08/20 11:33
Evaxion Biotech Q2 EPS $(0.01) Beats $(0.31) Estimate
Benzinga · 08/20 11:31
More
Webull provides a variety of real-time EVAX stock news. You can receive the latest news about Evaxion AS through multiple platforms. This information may help you make smarter investment decisions.
About EVAX
Evaxion A/S, formerly known as Evaxion Biotech A/S, is a Denmark-based clinical-stage biotechnology company, which specializes in the development of AI-driven immunotherapies to improve the lives of patients with cancer and infectious diseases. The Company decodes the human immune system to discover and develop immunotherapies to treat cancer and infectious diseases. Based on AI-immunology core technology, Evaxion is developing a pipeline of product candidates. In addition, Evaxion develops portfolio of vaccines to prevent bacterial and viral infections.